Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
-	ARID1A(9.6%)	exon16,c.3890_3891insT,p.E1297fs	0.096	0.00403	756|78	333|0	0.09818	1139|124	1	27100094	27100094	A	AT	PASS	ARID1A	NM_006015.6	16	c.3890_3891insT	p.Glu1297fs	frameshift_variant				27	0.0
1	NRAS(0.0%)	exon4,c.437C>T,p.A146V	0.0004252	0.0006264	9771|3	4175|1	0.00048	35127|17	1	115252203	115252203	G	A	clustered_events,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				49	0.0
1	NRAS(0.0%)	exon4,c.436G>T,p.A146S	0.0002134	0.0006113	9761|4	4188|2	0.00094	35143|33	1	115252204	115252204	C	A	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>T	p.Ala146Ser	missense_variant				22	0.0
1	NRAS(0.0%)	exon4,c.436G>C,p.A146P	0.0002905	0.0007016	9761|4	4188|2	0.00099	35143|35	1	115252204	115252204	C	G	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>C	p.Ala146Pro	missense_variant				35	0.0
1	NRAS(0.1%)	exon4,c.436G>A,p.A146T	0.000544	0.001325	9761|7	4188|5	0.00054	35143|19	1	115252204	115252204	C	T	clustered_events,normal_artifact,orientation,strand_bias,weak_evidence	NRAS	NM_002524.5	4	c.436G>A	p.Ala146Thr	missense_variant				36	0.0
1	NRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0009674	0.001106	4900|3	2302|1	0.00053	17088|9	1	115256536	115256536	C	T	clustered_events,strand_bias,weak_evidence	NRAS	NM_002524.5	3	c.175G>A	p.Ala59Thr	missense_variant	Likely_pathogenic		not_provided	29	0.0
1	NRAS(0.0%)	exon2,c.38G>T,p.G13V	0.0001682	0.0006378	10452|3	4683|3	0.00056	33856|19	1	115258744	115258750	CCACCTG	ACACCTG	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.38G>T	p.Gly13Val	missense_variant	Pathogenic/Likely_pathogenic		Acute_myeloid_leukemia|Neoplasm|Melanoma|Medulloblastoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Malignant_melanoma_of_skin|Non-Hodgkin_lymphoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome	27	0.0
1	NRAS(0.1%)	exon2,c.37G>A,p.G13S	0.0008611	0.0003246	10436|8	4690|0	0.00047	34012|16	1	115258745	115258750	C	T	clustered_events,weak_evidence	NRAS	NM_002524.5	2	c.37G>A	p.Gly13Ser	missense_variant	Likely_pathogenic		Neoplasm_of_stomach	14	0.0
1	NRAS(0.0%)	exon2,c.34G>A,p.G12S	0.0004224	0.0008502	10360|4	4638|2	0.00023	34572|8	1	115258748	115258750	C	T	clustered_events,orientation,weak_evidence	NRAS	NM_002524.5	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Acute_myeloid_leukemia|Melanoma|Multiple_myeloma|Malignant_melanoma_of_skin|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Noonan_syndrome_6|Myelodysplastic_syndrome|Noonan_syndrome|Rasopathy|Malignant_neoplasm_of_body_of_uterus|not_provided	32	0.0
	SPTA1(16.3%)	exon36,c.5041G>A,p.V1681I	0.163	0.044	425|76	29|0	0.15434	526|96	1	158607971	158607971	C	T	PASS	SPTA1	NM_003126.4	36	c.5041G>A	p.Val1681Ile	missense_variant				42	0.0
-	MSH6(5.2%)	exon5,c.3261del,p.F1088fs	0.052	0.046	4599|299	1260|68	0.04841	10222|520	2	48030639	48030640	AC	A	normal_artifact,panel_of_normals,slippage	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	44	0.0
	FANCL(1.8%)	exon8,c.683C>T,p.A228V	0.018	0.025	292|6	57|0	0.01504	393|6	2	58392882	58392882	G	A	PASS	FANCL	NM_001114636.1	8	c.683C>T	p.Ala228Val	missense_variant				19	0.0
	LRP1B(14.1%)	exon43,c.7027A>T,p.S2343C	0.141	0.143	184|26	9|0	0.13383	233|36	2	141356367	141356367	T	A	PASS	LRP1B	NM_018557.3	43	c.7027A>T	p.Ser2343Cys	missense_variant				39	0.0
	COBLL1(3.2%)	exon12,c.2720del,p.L907fs	0.032	0.048	2178|95	78|3	0.03469	4174|150	2	165551295	165551296	CA	C	multiallelic,panel_of_normals,slippage	COBLL1	NM_014900.5	12	c.2720del	p.Leu907fs	frameshift_variant				25	0.0
	COBLL1(3.5%)	exon12,c.2720dup,p.L907fs	0.035	0.017	2178|101	78|0	0.04398	4174|192	2	165551295	165551296	CA	CAA	multiallelic,panel_of_normals,slippage	COBLL1	NM_014900.5	12	c.2720dup	p.Leu907fs	frameshift_variant				35	0.0
2	CUL3(1.7%)	exon9,c.1207-3C>T	0.017	0.037	330|5	81|2	0.01435	412|6	2	225368542	225368542	G	A	normal_artifact	CUL3	NM_003590.5	8	c.1207-3C>T		splice_region_variant&intron_variant	Pathogenic		Pseudohypoaldosteronism_type_2A|Pseudohypoaldosteronism_type_2E	25	0.0
	ANO10(4.0%)	exon2,c.132del,p.D45fs	0.04	0.042	2464|129	385|20	0.04237	5538|245	3	43647212	43647213	CT	C	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia	43	0.0
	ANO10(2.6%)	exon2,c.132dup,p.D45fs	0.026	0.008356	2464|90	385|4	0.03603	5538|207	3	43647212	43647213	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Spinocerebellar_ataxia,_autosomal_recessive_10|Autosomal_recessive_cerebellar_ataxia|not_provided	46	0.0
	PIK3CB(1.7%)	exon12,c.1555G>A,p.A519T	0.017	0.022	465|8	73|0	0.01231	642|8	3	138423311	138423311	C	T	PASS	PIK3CB	NM_006219.3	12	c.1555G>A	p.Ala519Thr	missense_variant				51	0.0
	ATR(6.7%)	exon10,c.2320del,p.I774fs	0.067	0.049	5294|454	2300|148	0.06141	16108|1054	3	142274739	142274741	ATT	AT	multiallelic,normal_artifact,panel_of_normals	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	44	0.0
	ATR(3.3%)	exon10,c.2320dup,p.I774fs	0.033	0.04	5294|241	2300|130	0.05658	16108|966	3	142274739	142274741	ATT	ATTT	multiallelic,normal_artifact,panel_of_normals	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	41	0.0
	PRKCI(1.2%)	exon18,c.1768A>G,p.M590V	0.012	0.045	502|6	34|0	0.00821	725|6	3	170020892	170020892	A	G	PASS	PRKCI	NM_002740.6	18	c.1768A>G	p.Met590Val	missense_variant				49	0.0
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.00076	0.001934	5551|3	814|0	0.00039	18152|7	3	178936082	178936082	G	A	clustered_events,strand_bias,weak_evidence	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Squamous_cell_carcinoma_of_the_head_and_neck|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Brain_malformation|Glioblastoma|Lip_and_oral_cavity_carcinoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided	69	0.0
1	PIK3CA(0.0%)	exon10,c.1633G>C,p.E545Q	0.0002758	0.001916	5430|3	803|0	0.00085	17550|15	3	178936091	178936092	G	C	clustered_events,normal_artifact,orientation,weak_evidence	PIK3CA	NM_006218.4	10	c.1633G>C	p.Glu545Gln	missense_variant	Pathogenic/Likely_pathogenic,_drug_response		Histone_Methylation_Therapy_response|Hepatocellular_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Nasopharyngeal_Neoplasms|Neoplasm_of_the_large_intestine|Carcinoma_of_gallbladder|Adenocarcinoma_of_prostate|Head_and_Neck_Neoplasms|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus	40	0.0
1	PIK3CA(0.1%)	exon21,c.3139C>T,p.H1047Y	0.0009401	0.0009381	7382|7	1566|0	0.00073	31316|23	3	178952084	178952085	C	T	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	21	c.3139C>T	p.His1047Tyr	missense_variant	Pathogenic		Segmental_undergrowth_associated_with_mainly_venous_malformation_with_capillary_component|Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Congenital_macrodactylia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_stomach|Breast_neoplasm|Brainstem_glioma|Epidermal_nevus|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Seborrheic_keratosis|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Adenocarcinoma_of_prostate|Lung_carcinoma|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Cowden_syndrome_5|Cowden_syndrome|Familial_cancer_of_breast|Glioblastoma|Malignant_tumor_of_floor_of_mouth|Malignant_neoplasm_of_body_of_uterus|not_provided	46	0.0
1	PIK3CA(0.0%)	exon21,c.3140A>T,p.H1047L	0.0004018	0.0009527	7317|3	1552|0	0.00162	31484|51	3	178952085	178952085	A	T	clustered_events,orientation,weak_evidence	PIK3CA	NM_006218.4	21	c.3140A>T	p.His1047Leu	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Stroke|Hepatocellular_carcinoma|Hemihypertrophy|Medulloblastoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma,_papillary,_1|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Macrodactyly_of_toe|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Cowden_syndrome_1|Squamous_cell_carcinoma_of_the_head_and_neck|Megalencephaly-capillary_malformation-polymicrogyria_syndrome|Congenital_lipomatous_overgrowth,_vascular_malformations,_and_epidermal_nevi|Capillary_malformation_of_the_lower_lip,_lymphatic_malformation_of_face_and_neck,_asymmetry_of_face_and_limbs,_and_partial/generalized_overgrowth|Glioblastoma|Malignant_neoplasm_of_body_of_uterus|PIK3CA_related_overgrowth_spectrum	30	0.0
1	PIK3CA(0.0%)	exon21,c.3141T>A,p.H1047Q	0.0002336	0.0009612	7291|3	1547|0	0.00038	31352|12	3	178952086	178952086	T	A	base_qual,clustered_events,strand_bias,weak_evidence	PIK3CA	NM_006218.4	21	c.3141T>A	p.His1047Gln	missense_variant	Likely_pathogenic		Hepatocellular_carcinoma|Medulloblastoma|Adrenocortical_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Renal_cell_carcinoma	8	0.0
	KLHL6(1.6%)	exon5,c.1290C>T,p.D430=	0.016	0.017	411|7	75|0	0.01437	480|7	3	183211927	183211927	G	A	PASS	KLHL6	NM_130446.4	5	c.1290C>T	p.Asp430=	synonymous_variant				25	0.0
	MUC4(14.5%)	exon2,c.11677G>A,p.D3893N	0.145	0.126	34|5	8|0	0.08696	105|10	3	195506774	195506774	C	T	clustered_events,panel_of_normals	MUC4	NM_018406.7	2	c.11677G>A	p.Asp3893Asn	missense_variant				4	0.0
	MUC4(10.1%)	exon2,c.3002T>A,p.V1001E	0.101	0.172	55|6	4|0	0.15951	137|26	3	195515449	195515449	A	T	panel_of_normals	MUC4	NM_018406.7	2	c.3002T>A	p.Val1001Glu	missense_variant				8	0.0
	PDGFRA(0.2%)	exon18,c.2533C>T,p.H845Y	0.001823	0.0007489	5855|12	2141|0	0.00133	15727|21	4	55152101	55152101	C	T	clustered_events	PDGFRA	NM_006206.6	18	c.2533C>T	p.His845Tyr	missense_variant	Likely_pathogenic		Melanoma	28	0.0
1	KIT(0.0%)	exon11,c.1669T>A,p.W557R	0.0004793	0.001575	6273|5	2005|3	0.00134	20859|28	4	55593603	55593603	T	A	clustered_events,normal_artifact,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>A	p.Trp557Arg	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	62	0.0
	KIT(0.0%)	exon11,c.1669T>G,p.W557G	0.0002305	0.0007184	6273|3	2005|1	0.00081	20859|17	4	55593603	55593603	T	G	clustered_events,normal_artifact,strand_bias,weak_evidence	KIT	NM_000222.3	11	c.1669T>G	p.Trp557Gly	missense_variant	Likely_pathogenic		Gastrointestinal_stromal_tumor	7	0.0
1	KIT(0.0%)	exon11,c.1676T>G,p.V559G	0.0002345	0.002648	6214|7	1979|9	0.00354	20553|73	4	55593610	55593610	T	G	base_qual,clustered_events,weak_evidence	KIT	NM_000222.3	11	c.1676T>G	p.Val559Gly	missense_variant	Pathogenic/Likely_pathogenic		Melanoma|Gastrointestinal_stromal_tumor	41	0.0
1	KIT(0.2%)	exon14,c.2009C>T,p.T670I	0.001618	0.002826	5547|9	578|0	0.00073	16517|12	4	55595519	55595519	C	T	orientation,weak_evidence	KIT	NM_000222.3	14	c.2009C>T	p.Thr670Ile	missense_variant	Likely_pathogenic		Gastrointestinal_stromal_tumor	39	0.0
	KDR(1.5%)	exon15,c.2234G>A,p.C745Y	0.015	0.05	528|7	23|0	0.00925	750|7	4	55968096	55968096	C	T	PASS	KDR	NM_002253.3	15	c.2234G>A	p.Cys745Tyr	missense_variant				39	0.0
	SEC31A(0.3%)	exon11,c.1374C>T,p.C458=	0.003162	0.001538	3296|10	1024|0	0.00189	6849|13	4	83785575	83785575	G	A	PASS	SEC31A	NM_001077207.4	11	c.1374C>T	p.Cys458=	synonymous_variant				55	0.0
	MSH3(1.2%)	exon7,c.1148del,p.K383fs	0.012	0.007971	4463|85	1393|14	0.01908	11102|216	5	79970914	79970915	CA	C	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|none_provided|not_provided	35	0.0
	MSH3(1.8%)	exon7,c.1148dup,p.N385fs	0.018	0.017	4463|105	1393|30	0.02125	11102|241	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,panel_of_normals,slippage	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic		not_provided	39	0.0
	RAD50(5.1%)	exon13,c.2165del,p.K722fs	0.051	0.039	10391|671	4387|227	0.04824	56905|2884	5	131931451	131931453	TAA	TA	multiallelic,normal_artifact,panel_of_normals	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	43	0.0
	RAD50(0.1%)	exon13,c.2164_2165del,p.K722fs	0.00146	0.00168	10391|24	4387|8	0.00163	56905|93	5	131931451	131931453	TAA	T	multiallelic,normal_artifact,panel_of_normals	RAD50	NM_005732.4	13	c.2164_2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome	51	0.0
	RAD50(1.4%)	exon13,c.2165dup,p.E723fs	0.014	0.019	10391|242	4387|127	0.03106	56905|1824	5	131931451	131931453	TAA	TAAA	multiallelic,normal_artifact,panel_of_normals	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	40	0.0
	CSF1R(2.7%)	exon11,c.1596_1598del,p.L533del	0.027	0.03	275|6	51|0	0.01705	346|6	5	149447805	149447808	GAGC	G	panel_of_normals,slippage	CSF1R	NM_005211.4	11	c.1596_1598del	p.Leu533del	disruptive_inframe_deletion				47	0.0
	NPM1(3.1%)	exon7,c.538_540del,p.D180del	0.031	0.022	270|7	57|0	0.01770	333|6	5	170827156	170827159	GTGA	G	panel_of_normals,slippage	NPM1	NM_002520.7	7	c.538_540del	p.Asp180del	conservative_inframe_deletion	Uncertain_significance		not_provided	22	0.0
	NSD1(42.2%)	exon5,c.3540A>G,p.K1180=	0.422	0.143	43|30	6|0	0.44304	44|35	5	176638940	176638940	A	G	PASS	NSD1	NM_022455.5	5	c.3540A>G	p.Lys1180=	synonymous_variant	Benign		Sotos_syndrome_1	37	0.0
	FLT4(14.3%)	exon13,c.1942G>A,p.E648K	0.143	0.051	63|9	24|0	0.12162	65|9	5	180048620	180048620	C	T	PASS	FLT4	NM_182925.5	13	c.1942G>A	p.Glu648Lys	missense_variant				27	0.0
	DAXX(1.9%)	exon4,c.1114C>T,p.R372C	0.019	0.014	478|8	114|0	0.01318	599|8	6	33288330	33288330	G	A	PASS	DAXX	NM_001141970.2	4	c.1114C>T	p.Arg372Cys	missense_variant				35	0.0
	PMS2(1.6%)	exon10,c.993C>T,p.C331=	0.016	0.029	332|6	47|0	0.02294	426|10	7	6029582	6029582	G	A	PASS	PMS2	NM_000535.7	10	c.993C>T	p.Cys331=	synonymous_variant	Benign/Likely_benign		Lynch_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided	39	0.0
	RAC1(1.2%)	exon3,c.219G>A,p.P73=	0.012	0.007691	1124|14	208|0	0.01250	1422|18	7	6431666	6431666	G	A	PASS	RAC1	NM_018890.4	3	c.219G>A	p.Pro73=	synonymous_variant				35	0.0
1	EGFR(0.0%)	exon19,c.2239_2256del,p.L747_S752del	0.0001503	0.0004061	10452|1	3949|0	0.00000	27100|0	7	55242468	55242486	ATTAAGAGAAGCAACATCT	A	base_qual,clustered_events,weak_evidence	EGFR	NM_005228.5	19	c.2239_2256del	p.Leu747_Ser752del	conservative_inframe_deletion	drug_response		Tyrosine_kinase_inhibitor_response	50	0.0
1	EGFR(0.2%)	exon20,c.2303G>T,p.S768I	0.001516	0.001992	2037|3	775|0	0.00109	3651|4	7	55249005	55249005	G	T	clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2303G>T	p.Ser768Ile	missense_variant	Pathogenic		Carcinoma_of_esophagus|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma	48	0.0
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.0008619	0.001359	3689|4	1170|1	0.00143	6995|10	7	55259515	55259515	T	G	base_qual,clustered_events,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Lung_carcinoma|Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Erlotinib_response|Gefitinib_response|Tyrosine_kinase_inhibitor_response|gefitinib_response_-_Efficacy	35	0.0
	CYP3A4(0.5%)	exon11,c.1130G>A,p.C377Y	0.004825	0.002182	5314|25	1293|1	0.00353	11282|40	7	99359787	99359787	C	T	PASS	CYP3A4	NM_017460.6	11	c.1130G>A	p.Cys377Tyr	missense_variant				50	0.0
1	MET(0.0%)	exon14,c.2888-1G>A	0.0004982	0.0008186	8569|3	1686|0	0.00017	41383|7	7	116411902	116411902	G	A	orientation,strand_bias,weak_evidence	MET	NM_000245.4	13	c.2888-1G>A		splice_acceptor_variant&intron_variant				2	0.0
1	MET(0.0%)	exon14,c.3028G>T,p.D1010Y	0.0001753	0.0007753	8618|4	2003|3	0.00247	53341|132	7	116412043	116412043	G	T	clustered_events,strand_bias,weak_evidence	MET	NM_000245.4	14	c.3028G>T	p.Asp1010Tyr	missense_variant&splice_region_variant				35	0.0
1	MET(0.0%)	exon14,c.3028+2T>A	0.0001783	0.0007805	8547|3	1988|2	0.00079	52971|42	7	116412045	116412045	T	A	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+2T>A		splice_donor_variant&intron_variant				33	0.0
1	MET(0.1%)	exon14,c.3028+2T>C	0.0006693	0.0007754	8547|5	1988|0	0.00058	52971|31	7	116412045	116412045	T	C	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+2T>C		splice_donor_variant&intron_variant	not_provided		not_provided	48	0.0
1	MET(0.1%)	exon14,c.3028+3A>G	0.0005195	0.000778	8474|4	1971|1	0.00023	52648|12	7	116412046	116412046	A	G	clustered_events,orientation,weak_evidence	MET	NM_000245.4	14	c.3028+3A>G		splice_region_variant&intron_variant				29	0.0
0	BRAF(0.0%)	exon15,c.1803A>C,p.K601N	0.0002242	0.001788	6852|3	879|0	0.00064	27903|18	7	140453132	140453132	T	G	base_qual,clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1803A>C	p.Lys601Asn	missense_variant	Uncertain_significance		Melanoma|B-cell_chronic_lymphocytic_leukemia|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_thyroid_gland|Adenocarcinoma_of_prostate|Rasopathy|Malignant_neoplasm_of_body_of_uterus	32	0.0
	BRAF(0.0%)	exon15,c.1802A>T,p.K601I	0.0002256	0.001814	6864|3	880|1	0.00132	27977|37	7	140453133	140453133	T	A	base_qual,clustered_events,strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1802A>T	p.Lys601Ile	missense_variant	Likely_pathogenic		Cardio-facio-cutaneous_syndrome|Rasopathy|not_provided	25	0.0
1	BRAF(0.0%)	exon15,c.1799T>A,p.V600E	0.0002242	0.002266	6750|3	865|2	0.00167	27453|46	7	140453136	140453137	A	T	clustered_events,orientation,weak_evidence	BRAF	NM_004333.6	15	c.1799T>A	p.Val600Glu	missense_variant	Pathogenic,_drug_response,_other		Cystic_epithelial_invagination_containing_papillae_lined_by_columnar_epithelium|Trametinib-Dabrafenib_Response|Vemurafenib-Cobimetinib_Response|Nephroblastoma|Cerebral_arteriovenous_malformation|Neoplasm|Melanoma|Papillary_thyroid_carcinoma|Multiple_myeloma|Brainstem_glioma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_brain|Colonic_neoplasm|Neoplasm_of_ovary|Gastrointestinal_stromal_tumor|Neoplasm_of_the_large_intestine|Carcinoma_of_colon|Malignant_neoplastic_disease|Lung_carcinoma|Colorectal_cancer|Squamous_cell_carcinoma_of_the_head_and_neck|Cardio-facio-cutaneous_syndrome|Glioblastoma|Papillary_renal_cell_carcinoma,_sporadic|Germ_cell_tumor,_nonseminomatous|Astrocytoma,_low-grade,_somatic|not_provided	26	0.0
-	KMT2C(2.5%)	exon38,c.8390dup,p.E2798fs	0.025	0.026	7022|230	3329|121	0.03987	24177|1004	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,panel_of_normals,slippage	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	36	0.0
	JAK2(1.5%)	exon6,c.474G>A,p.R158=	0.015	0.038	358|5	33|0	0.01699	463|8	9	5050691	5050691	G	A	PASS	JAK2	NM_004972.4	6	c.474G>A	p.Arg158=	synonymous_variant				53	0.0
	FANCC(1.2%)	exon8,c.736C>T,p.H246Y	0.012	0.004578	1236|15	334|0	0.00811	1835|15	9	97897735	97897735	G	A	PASS	FANCC	NM_000136.3	8	c.736C>T	p.His246Tyr	missense_variant				47	0.0
1	RET(0.0%)	exon16,c.2753T>C,p.M918T	0.0002416	0.0005493	13476|5	5688|2	0.00016	64189|10	10	43617416	43617416	T	C	orientation,strand_bias,weak_evidence	RET	NM_020975.6	16	c.2753T>C	p.Met918Thr	missense_variant	Pathogenic/Likely_pathogenic		Gingival_overgrowth|Hypertelorism|Hypothyroidism|Joint_hypermobility|Short_stature|Tetralogy_of_Fallot|Constipation|Pheochromocytoma|Medullary_thyroid_carcinoma|Thick_vermilion_border|Neoplasm_of_the_thyroid_gland|Multiple_endocrine_neoplasia,_type_1|Hirschsprung_disease_1|Familial_medullary_thyroid_carcinoma|Multiple_endocrine_neoplasia,_type_2b|Multiple_endocrine_neoplasia,_type_2a|Multiple_endocrine_neoplasia,_type_4|Multiple_endocrine_neoplasia,_type_2|Inborn_genetic_diseases|Thyroid_carcinoma,_sporadic_medullary|not_specified|not_provided	38	0.0
	IFITM3(12.0%)	exon1,c.91G>A,p.V31M	0.12	0.048	104|12	27|0	0.10870	123|15	11	320723	320723	C	T	haplotype,orientation,panel_of_normals	IFITM3	NM_021034.3	1	c.91G>A	p.Val31Met	missense_variant				7	0.0
	IFITM3(10.3%)	exon1,c.81_84delinsGGAA,p.H27Q	0.103	0.053	97|8	25|0	0.04425	108|5	11	320730	320733	CTCG	TTCC	haplotype	IFITM3	NM_021034.3	1	c.81_84delinsGGAA	p.His27Gln	missense_variant				7	0.0
	MUC6(2.8%)	exon31,c.4856T>C,p.F1619S	0.028	0.016	586|10	90|0	0.02932	927|28	11	1017945	1017945	A	G	clustered_events,panel_of_normals,strand_bias	MUC6	NM_005961.3	31	c.4856T>C	p.Phe1619Ser	missense_variant				17	0.0
	MUC6(3.2%)	exon31,c.4800T>G,p.T1600=	0.032	0.014	625|17	100|1	0.06758	883|64	11	1018001	1018001	A	C	clustered_events,haplotype,panel_of_normals	MUC6	NM_005961.3	31	c.4800T>G	p.Thr1600=	synonymous_variant				44	0.0
	MUC6(3.1%)	exon31,c.4786T>A,p.F1596I	0.031	0.015	583|15	95|1	0.07293	750|59	11	1018015	1018015	A	T	clustered_events,haplotype,panel_of_normals	MUC6	NM_005961.3	31	c.4786T>A	p.Phe1596Ile	missense_variant				34	0.0
	IGF2(4.2%)	exon4,c.510C>T,p.G170=	0.042	0.063	92|3	19|0	0.02459	119|3	11	2154250	2154250	G	A	PASS	IGF2	NM_000612.6	4	c.510C>T	p.Gly170=	synonymous_variant				20	0.0
	FANCF(7.9%)	exon1,c.457G>A,p.E153K	0.079	0.053	49|3	23|0	0.04478	64|3	11	22646900	22646900	C	T	PASS	FANCF	NM_022725.4	1	c.457G>A	p.Glu153Lys	missense_variant	Uncertain_significance		Fanconi_anemia	42	0.0
	ESRRA(9.5%)	exon7,c.1086T>C,p.Y362=	0.095	0.057	109|9	25|0	0.09150	139|14	11	64083252	64083252	T	C	clustered_events,panel_of_normals	ESRRA	NM_004451.5	7	c.1086T>C	p.Tyr362=	synonymous_variant				30	0.0
	ESRRA(14.3%)	exon7,c.1103_1132delinsACCCCGGTGGGGGTGCTGAGCAGCTGC,p.G368_A378>DPGGGAEQLP	0.143	0.058	88|13	23|0	0.14504	112|19	11	64083269	64083298	GCCCCGGAGGGGGTGCTGAGCGGCGGCGGG	ACCCCGGTGGGGGTGCTGAGCAGCTGC	clustered_events,haplotype,panel_of_normals	ESRRA	NM_004451.5	7	c.1103_1132delinsACCCCGGTGGGGGTGCTGAGCAGCTGC	p.Gly368_Ala378delinsAspProGlyGlyGlyAlaGluGlnLeuPro	missense_variant&disruptive_inframe_deletion				22	0.0
	ESRRA(20.8%)	exon7,c.1152_1154delinsACC,p.L385P	0.208	0.071	53|19	15|0	0.31522	63|29	11	64083318	64083320	GCT	ACC	clustered_events,haplotype,panel_of_normals	ESRRA	NM_004451.5	7	c.1152_1154delinsACC	p.Leu385Pro	missense_variant				50	0.0
	ESRRA(20.4%)	exon7,c.1162_1165delinsTTCT,p.L388_R389>FC	0.204	0.067	53|19	16|0	0.32258	63|30	11	64083328	64083331	CTCC	TTCT	clustered_events,haplotype,panel_of_normals	ESRRA	NM_004451.5	7	c.1162_1165delinsTTCT	p.Leu388_Arg389delinsPheCys	missense_variant				44	0.0
-	ATM(3.2%)	exon10,c.1236-2A>T	0.032	0.029	644|27	96|2	0.06304	1308|88	11	108121426	108121426	A	T	base_qual,normal_artifact,panel_of_normals	ATM	NM_000051.4	9	c.1236-2A>T		splice_acceptor_variant&intron_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome	32	0.0
	CD3G(4.7%)	exon3,c.213del,p.K71fs	0.047	0.044	2215|118	584|28	0.04520	4119|195	11	118220582	118220583	TA	T	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1),Uncertain_significance(1)	Immunodeficiency_17	44	0.0
	CD3G(2.0%)	exon3,c.213dup,p.W72fs	0.02	0.012	2215|56	584|6	0.02416	4119|102	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,panel_of_normals,slippage	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Immunodeficiency_17	47	0.0
	CHD4(6.1%)	exon4,c.414_417delinsT,p.E138_E139>D	0.061	0.067	104|6	21|0	0.66667	3|6	12	6711147	6711150	CTCC	A	haplotype,panel_of_normals,slippage	CHD4	NM_001273.5	4	c.414_417delinsT	p.Glu138_Glu139delinsAsp	missense_variant&conservative_inframe_deletion				33	0.0
1	KRAS(0.1%)	exon4,c.437C>T,p.A146V	0.0006989	0.0008369	6719|4	1879|0	0.00056	33728|19	12	25378561	25378562	G	A	weak_evidence	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	47	0.0
1	KRAS(0.1%)	exon4,c.436G>T,p.A146S	0.0009123	0.0008349	6768|6	1886|1	0.00188	34018|64	12	25378562	25378562	C	A	weak_evidence	KRAS	NM_033360.4	4	c.436G>T	p.Ala146Ser	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Uncertain_significance(1)	Rasopathy|not_provided	51	0.0
1	KRAS(0.1%)	exon3,c.175G>T,p.A59S	0.001062	0.0006079	5927|7	2660|0	0.00119	25130|30	12	25380283	25380283	C	A	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>T	p.Ala59Ser	missense_variant	Pathogenic/Likely_pathogenic		not_provided	25	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0005308	0.002332	5927|3	2660|5	0.00099	25130|25	12	25380283	25380283	C	T	clustered_events,orientation,strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	41	0.0
1	KRAS(0.1%)	exon2,c.38G>A,p.G13D	0.0006259	0.0007017	7811|5	3799|1	0.00037	32821|12	12	25398281	25398282	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.38G>A	p.Gly13Asp	missense_variant	Pathogenic		OCULOECTODERMAL_SYNDROME,_SOMATIC|Acute_myeloid_leukemia|Nevus_sebaceous|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Breast_adenocarcinoma|RAS-associated_autoimmune_leukoproliferative_disorder|Inborn_genetic_diseases|not_provided	26	0.0
1	KRAS(0.1%)	exon2,c.37G>A,p.G13S	0.0007604	0.001213	7812|7	3801|4	0.00024	32978|8	12	25398282	25398282	C	T	clustered_events,normal_artifact,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.37G>A	p.Gly13Ser	missense_variant	Pathogenic		Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_the_large_intestine	42	0.0
1	KRAS(0.1%)	exon2,c.35G>A,p.G12D	0.0006002	0.0004074	7801|4	3798|0	0.00034	32723|11	12	25398284	25398285	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.35G>A	p.Gly12Asp	missense_variant	Pathogenic		Vascular_Tumors_Including_Pyogenic_Granuloma|Acute_myeloid_leukemia|Cerebral_arteriovenous_malformation|Neoplasm_of_stomach|Nevus_sebaceous|Epidermal_nevus|Epidermal_nevus_syndrome|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Carcinoma_of_pancreas|RAS-associated_autoimmune_leukoproliferative_disorder|Rasopathy|Primary_low_grade_serous_adenocarcinoma_of_ovary|not_provided	33	0.0
1	KRAS(0.0%)	exon2,c.34G>T,p.G12C	0.0003421	0.0004496	7782|6	3800|2	0.00103	32862|34	12	25398285	25398285	C	A	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>T	p.Gly12Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1),Pathogenic(7),Uncertain_significance(1)	Endometrial_carcinoma|Lung_adenocarcinoma|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Lung_carcinoma|Gallbladder_cancer|not_provided	10	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.0007648	0.0004089	7782|6	3800|0	0.00097	32862|32	12	25398285	25398285	C	T	clustered_events,strand_bias,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Gastric_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Neoplasm_of_the_thyroid_gland|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|not_provided	50	0.0
	KMT2D(24.8%)	exon40,c.12391C>T,p.P4131S	0.248	0.167	13|3	6|0	0.15000	17|3	12	49426097	49426097	G	A	PASS	KMT2D	NM_003482.4	40	c.12391C>T	p.Pro4131Ser	missense_variant				34	0.0
-	KMT2D(0.1%)	exon11,c.2264_2310del,p.R755fs	0.001189	0.001069	9164|15	6273|10	0.00000	17641|0	12	49445155	49445202	ACAGGTGTGGCTCCTCAGCCTGCGGAGATAGGTGTGGCTCCTCAGGCC	A	clustered_events,normal_artifact,panel_of_normals	KMT2D	NM_003482.4	11	c.2264_2310del	p.Arg755fs	frameshift_variant	Likely_pathogenic		Kabuki_syndrome_1	19	0.0
-	KMT2D(0.5%)	exon11,c.1824_1899del,p.S609fs	0.00525	0.007181	1637|30	391|12	0.00000	485|0	12	49445566	49445642	GCGAGTCCTCAGGTGGTGGGGACAGGCGTGATGCCTCAGGTGGTGGGGAAAGGGGAGACTCCTCAGGTGGAGGGGAC	G	clustered_events,normal_artifact,panel_of_normals,weak_evidence	KMT2D	NM_003482.4	11	c.1824_1899del	p.Ser609fs	frameshift_variant	Pathogenic		Kabuki_syndrome	27	0.0
	FAM186A(10.0%)	exon4,c.4593G>C,p.L1531=	0.1	0.075	46|4	14|0	0.16071	94|18	12	50746022	50746022	C	G	PASS	FAM186A	NM_001145475.3	4	c.4593G>C	p.Leu1531=	synonymous_variant				42	0.0
	GLI1(7.3%)	exon4,c.336G>A,p.S112=	0.073	0.014	418|37	94|0	0.07881	526|45	12	57858598	57858598	G	A	PASS	GLI1	NM_005269.3	4	c.336G>A	p.Ser112=	synonymous_variant				38	0.0
-	BRCA2(2.1%)	exon10,c.1813del,p.I605fs	0.021	0.021	3224|87	503|11	0.02384	7248|177	13	32907420	32907421	GA	G	normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	40	0.0
-	BRCA2(0.6%)	exon11,c.2588del,p.N863fs	0.005524	0.032	1827|14	101|4	0.00652	3047|20	13	32911073	32911074	CA	C	normal_artifact,weak_evidence	BRCA2	NM_000059.4	11	c.2588del	p.Asn863fs	frameshift_variant	Pathogenic		Familial_cancer_of_breast	39	0.0
-	BRCA2(0.9%)	exon11,c.5073del,p.K1691fs	0.00892	0.019	2288|27	302|4	0.01070	4529|49	13	32913558	32913559	CA	C	normal_artifact,weak_evidence	BRCA2	NM_000059.4	11	c.5073del	p.Lys1691fs	frameshift_variant	Pathogenic		Breast-ovarian_cancer,_familial_2|not_provided	42	0.0
-	BRCA2(0.7%)	exon11,c.5351del,p.N1784fs	0.006627	0.023	2925|29	516|12	0.00820	5923|49	13	32913836	32913837	CA	C	normal_artifact,panel_of_normals,weak_evidence	BRCA2	NM_000059.4	11	c.5351del	p.Asn1784fs	frameshift_variant	Pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|not_provided	36	0.0
-	BRCA2(1.5%)	exon23,c.9097dup,p.T3033fs	0.015	0.018	2823|55	691|15	0.02146	5654|124	13	32954022	32954022	C	CA	normal_artifact,panel_of_normals,slippage	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Breast_carcinoma|Neoplasm_of_ovary|Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial_1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Breast_and/or_ovarian_cancer|not_provided	43	0.0
	HSP90AA1(4.1%)	exon6,c.1202_1204del,p.K401del	0.041	0.041	142|6	17|0	0.02740	284|8	14	102551160	102551163	ATCT	A	panel_of_normals,slippage	HSP90AA1	NM_001017963.3	6	c.1202_1204del	p.Lys401del	disruptive_inframe_deletion				44	0.0
	PHGR1(21.7%)	exon4,c.135_200del,p.P46_P67del	0.217	0.058	176|4	76|0	0.00000	230|0	15	40648314	40648380	ACTGCGGGCCACCCCCTGGCCATGGCCCAGGGCCCTGCGGGCCACCCCCCCACCATGGTCCAGGGCC	A	panel_of_normals,slippage	PHGR1	NM_001145643.2	4	c.135_200del	p.Pro46_Pro67del	disruptive_inframe_deletion				46	0.0
	MAP2K1(13.5%)	exon6,c.607G>A,p.E203K	0.135	0.002241	2030|315	721|0	0.13781	3441|550	15	66774131	66774131	G	A	PASS	MAP2K1	NM_002755.4	6	c.607G>A	p.Glu203Lys	missense_variant	Likely_pathogenic		Melanoma|Inborn_genetic_diseases	38	0.0
	BLM(2.3%)	exon7,c.1544del,p.N515fs	0.023	0.018	11508|348	6771|174	0.02453	72986|1835	15	91304138	91304139	GA	G	multiallelic,normal_artifact,panel_of_normals	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	41	0.0
	BLM(1.5%)	exon7,c.1544dup,p.N515fs	0.015	0.013	11508|248	6771|134	0.02710	72986|2033	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,panel_of_normals	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_breast_and_ovarian_cancer_syndrome|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome	42	0.0
	CHD2(4.3%)	exon29,c.3734del,p.K1245fs	0.043	0.023	1130|63	252|6	0.04241	1761|78	15	93540315	93540316	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Pathogenic/Likely_pathogenic		Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_provided	43	0.0
	CHD2(2.2%)	exon33,c.4173del,p.K1391fs	0.022	0.013	380|9	73|0	0.01651	536|9	15	93545433	93545434	GA	G	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	33	c.4173del	p.Lys1391fs	frameshift_variant	Likely_pathogenic		Intellectual_disability	30	0.0
	CHD2(3.6%)	exon33,c.4173dup,p.Q1392fs	0.036	0.076	380|12	73|6	0.03249	536|18	15	93545433	93545434	GA	GAA	multiallelic,normal_artifact,panel_of_normals,slippage	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3),Uncertain_significance(1)	CHD2-Related_Disorder|Autistic_behavior|Seizures|Developmental_and_epileptic_encephalopathy_94|Complex_neurodevelopmental_disorder|not_provided	28	0.0
	CDH1(4.7%)	exon2,c.68A>G,p.Q23R	0.047	0.034	99|4	44|0	0.03361	115|4	16	68772219	68772219	A	G	orientation	CDH1	NM_004360.5	2	c.68A>G	p.Gln23Arg	missense_variant				53	0.0
	PLCG2(4.6%)	exon11,c.876G>A,p.T292=	0.046	0.07	131|5	21|0	0.03226	150|5	16	81925085	81925085	G	A	PASS	PLCG2	NM_002661.5	11	c.876G>A	p.Thr292=	synonymous_variant	Likely_benign		Familial_cold_autoinflammatory_syndrome_3	49	0.0
	FANCA(1.5%)	exon8,c.787C>T,p.P263S	0.015	0.022	468|7	66|0	0.01199	577|7	16	89869672	89869672	G	A	PASS	FANCA	NM_000135.4	8	c.787C>T	p.Pro263Ser	missense_variant				21	0.0
	TP53(14.6%)	exon8,c.818G>A,p.R273H	0.146	0.0006591	4852|858	2181|0	0.14928	13364|2345	17	7577120	7577120	C	T	PASS	TP53	NM_000546.6	8	c.818G>A	p.Arg273His	missense_variant	Pathogenic		Li-Fraumeni_syndrome_1|Hepatocellular_carcinoma|Acute_myeloid_leukemia|Neoplasm|Rhabdomyosarcoma|Medulloblastoma|Adrenocortical_carcinoma|B-cell_chronic_lymphocytic_leukemia|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Multiple_myeloma|Breast_neoplasm|Brainstem_glioma|Carcinoma_of_esophagus|Thyroid_gland_undifferentiated_(anaplastic)_carcinoma|Malignant_melanoma_of_skin|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Adenocarcinoma_of_stomach|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Choroid_plexus_papilloma|Carcinoma_of_colon|Bone_osteosarcoma|Adenocarcinoma_of_prostate|Carcinoma_of_pancreas|Colorectal_cancer|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Malignant_tumor_of_breast|Adrenocortical_carcinoma,_hereditary|Squamous_cell_carcinoma_of_the_head_and_neck|Basal_cell_carcinoma,_susceptibility_to,_7|Hereditary_cancer-predisposing_syndrome|Nasopharyngeal_carcinoma|Familial_cancer_of_breast|Glioblastoma|Li-Fraumeni_syndrome|Glioma_susceptibility_1|Malignant_neoplasm_of_body_of_uterus|not_specified|not_provided	37	0.0
	CDK12(7.8%)	exon6,c.2573G>A,p.R858Q	0.078	0.003655	1722|146	401|0	0.08233	2441|219	17	37657656	37657656	G	A	PASS	CDK12	NM_016507.4	6	c.2573G>A	p.Arg858Gln	missense_variant				35	0.0
	ERBB2(0.4%)	exon27,c.3569C>T,p.A1190V	0.004138	0.00447	3075|13	1026|4	0.00275	6901|19	17	37884098	37884098	C	T	PASS	ERBB2	NM_004448.4	27	c.3569C>T	p.Ala1190Val	missense_variant				43	0.0
	XYLT2(1.9%)	exon8,c.1584del,p.G529fs	0.019	0.005827	1544|46	523|3	0.02142	2878|63	17	48433966	48433967	AC	A	panel_of_normals	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondyloocular_syndrome	38	0.0
	RPTOR(1.3%)	exon31,c.3650C>T,p.A1217V	0.013	0.012	536|6	125|0	0.00777	766|6	17	78935238	78935238	C	T	PASS	RPTOR	NM_020761.3	31	c.3650C>T	p.Ala1217Val	missense_variant				50	0.0
	TXNDC2(8.9%)	exon2,c.882_886delinsTAAGA,p.E296K	0.089	0.039	208|15	41|2	0.11663	462|61	18	9887358	9887362	CAAGG	TAAGA	clustered_events,haplotype,panel_of_normals,strand_bias	TXNDC2	NM_001098529.2	2	c.882_886delinsTAAGA	p.Glu296Lys	missense_variant				12	0.0
	TXNDC2(4.4%)	exon2,c.895_972del,p.L299_P324del	0.044	0.021	314|11	67|1	0.00000	1|0	18	9887369	9887447	ACCTCCCCAAGTCCCTAGAGGAAGCCATCCAGCCCAAGGAGGGTGACATCCCCAAGTCCCCAGAAGAAGCCATCCAGCC	A	clustered_events,haplotype	TXNDC2	NM_001098529.2	2	c.895_972del	p.Leu299_Pro324del	conservative_inframe_deletion				2	0.0
-	SMAD4(19.5%)	exon6,c.780C>A,p.Y260*	0.195	0.02	304|74	69|0	0.19149	418|99	18	48584607	48584607	C	A	PASS	SMAD4	NM_005359.6	6	c.780C>A	p.Tyr260*	stop_gained	Pathogenic		Juvenile_polyposis_syndrome	31	0.0
	BRD4(12.5%)	exon10,c.1762C>T,p.P588S	0.125	0.111	26|3	8|0	0.09677	28|3	19	15366393	15366393	G	A	PASS	BRD4	NM_058243.3	10	c.1762C>T	p.Pro588Ser	missense_variant				52	0.0
	BAX(1.6%)	exon3,c.121del,p.E41fs	0.016	0.017	1657|38	374|6	0.02058	3189|67	19	49458970	49458971	TG	T	normal_artifact,panel_of_normals,slippage	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	45	0.0
	PPP2R1A(23.4%)	exon5,c.548G>A,p.R183Q	0.234	0.001938	1400|446	720|0	0.24544	2690|875	19	52715983	52715983	G	A	PASS	PPP2R1A	NM_014225.6	5	c.548G>A	p.Arg183Gln	missense_variant	Pathogenic/Likely_pathogenic		Breast_neoplasm|Lung_adenocarcinoma|Adenocarcinoma_of_stomach|Neoplasm_of_the_large_intestine|Adenocarcinoma_of_prostate|Ovarian_Serous_Cystadenocarcinoma|Uterine_Carcinosarcoma|Squamous_cell_carcinoma_of_the_head_and_neck|Mental_retardation,_autosomal_dominant_36|Malignant_neoplasm_of_body_of_uterus|not_provided	37	0.0
	ARFRP1(6.8%)	exon4,c.234G>A,p.G78=	0.068	0.088	61|4	15|0	0.08219	67|6	20	62337739	62337739	C	T	orientation	ARFRP1	NM_001267547.3	4	c.234G>A	p.Gly78=	synonymous_variant				61	0.0
